Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
about
The interferon response inhibits HIV particle production by induction of TRIM22Visualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy.An early stage of Mason-Pfizer monkey virus budding is regulated by the hydrophobicity of the Gag matrix domain coreInhibition of HIV-1 particle assembly by 2',3'-cyclic-nucleotide 3'-phosphodiesteraseWrapping up the bad news: HIV assembly and releaseSingle-Cell and Single-Cycle Analysis of HIV-1 ReplicationHIV-1 matrix dependent membrane targeting is regulated by Gag mRNA traffickingLipids and membrane microdomains in HIV-1 replicationStructure of equine infectious anemia virus matrix protein.Point Mutations in the HIV-1 Matrix Protein Turn Off the Myristyl SwitchEntropic switch regulates myristate exposure in the HIV-1 matrix proteinStructure of the Myristylated Human Immunodeficiency Virus Type 2 Matrix Protein and the Role of Phosphatidylinositol-(4,5)-Bisphosphate in Membrane TargetingThe Structure of Myristoylated Mason-Pfizer Monkey Virus Matrix Protein and the Role of Phosphatidylinositol-(4,5)-Bisphosphate in Its Membrane BindingTrio engagement via plasma membrane phospholipids and the myristoyl moiety governs HIV-1 matrix binding to bilayersHuman immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity.Design of in vitro symmetric complexes and analysis by hybrid methods reveal mechanisms of HIV capsid assemblyThe structural biology of HIV assembly.Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag.Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assayMobility of human immunodeficiency virus type 1 Pr55Gag in living cells.Analysis of the initiating events in HIV-1 particle assembly and genome packagingHow HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cellsOpposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.Structural characterization of membrane-bound human immunodeficiency virus-1 Gag matrix with neutron reflectometry.Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling.Biochemical characterization of rous sarcoma virus MA protein interaction with membranes.Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly.Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.A block to human immunodeficiency virus type 1 assembly in murine cells.Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates.Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes.Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly.The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.
P2860
Q21131598-C8D8A349-24A9-47B8-B243-352AFD51969DQ22241754-5165B8D9-C20A-43CD-A142-62A7E38C6DACQ24567661-B09744B8-8CBA-4EE5-AAD5-05ED7E25E566Q24612444-BE99B8F3-882A-4ECF-BD59-986EF994787EQ26992150-65529622-8367-44B2-A700-9DC72963CEF6Q27319151-E135412F-FB07-47CB-A120-E0500389B4F9Q27345288-CC1B2832-C915-43E2-9325-300B1D465381Q27489393-27B1BCC7-1A06-4FC1-B87A-D0264AF52A18Q27637386-F15F0613-416B-41A5-ADBA-ADAB8011AE73Q27640933-3F4BE54C-78A5-402F-9C23-BBA8CE4273DBQ27642873-DB23DE66-2DF6-42EF-A925-1C38D66C9D38Q27651354-AACE4B7E-99E6-430D-8F30-4E2CFFFCC089Q27671147-039E6C23-9C7E-40F5-A261-8F9C636F7683Q27676343-3E7269AA-AD44-458E-B0F3-ADAE5FD6FED4Q30312050-92D86423-B69D-4608-8B0C-150686D87A33Q30425900-1771C8D3-55BA-47F2-9F38-6D820FA1069BQ30437103-FA8B5B11-B9E3-4E1B-8F0B-9C5A49D844B4Q30443327-89ABDC39-276E-4BCE-B8BC-C1DC613760B5Q30447057-EC232590-6F84-48E9-A06C-02338B93A79DQ30477939-1E4EE43E-49EB-412C-B17E-225F467EEAC0Q30992792-09ECA92C-E4C2-49DC-9C72-528ED1CC9DF2Q33358839-3B80F38D-3AD6-4C07-9441-8861F69C1BCCQ33422993-D0D94635-BDDD-4649-84F7-1BE8B180BBD3Q33642818-E24AF5FA-71FE-4DDB-BB16-8DE063288703Q33647588-D82990F1-195C-48A4-8578-DA1931B68878Q33667586-1D4FF983-78A7-4D82-BC30-883543FFADD0Q33694200-19934366-836F-4546-BB39-FCE92AC9A1D6Q33707507-020D24C2-A9D7-4437-80AD-BCFAA8AB3C9CQ33780632-321031A3-B66C-4F14-8232-12259406791BQ33782781-8D6F1415-1E5E-4C4A-8B48-254FABA6E714Q33785479-8FB78E4B-FCB8-4642-9AD5-11808C6FDC79Q33787084-6B613FA3-7F4D-4792-8FA0-7746074A22B4Q33800293-EA2154F0-92BE-4EE0-AFD1-5007A92C1920Q33802821-4D45DC44-413B-4679-98EE-2CB9D89CF9AAQ33806395-1ECFEA5F-61E3-4A76-B46A-BE30ACB5E2ACQ33809347-29B33487-3C0D-4F19-9C78-582EC71A1F3BQ33813747-EE46CA07-699C-46FC-A65A-8183881BDAB9Q33815436-F153B398-ACDD-4AF5-91EB-3543F221D61AQ33837992-D9B19D60-4258-4023-8243-8A8EAE9E7D43Q33841842-EC54EB98-75FA-446F-87D2-AC842A6C888D
P2860
Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Membrane binding of human immu ...... nal myristyl switch mechanism.
@ast
Membrane binding of human immu ...... nal myristyl switch mechanism.
@en
Membrane binding of human immu ...... nal myristyl switch mechanism.
@nl
type
label
Membrane binding of human immu ...... nal myristyl switch mechanism.
@ast
Membrane binding of human immu ...... nal myristyl switch mechanism.
@en
Membrane binding of human immu ...... nal myristyl switch mechanism.
@nl
prefLabel
Membrane binding of human immu ...... nal myristyl switch mechanism.
@ast
Membrane binding of human immu ...... nal myristyl switch mechanism.
@en
Membrane binding of human immu ...... nal myristyl switch mechanism.
@nl
P2093
P2860
P1433
P1476
Membrane binding of human immu ...... nal myristyl switch mechanism.
@en
P2093
P2860
P304
P407
P577
1997-09-01T00:00:00Z